(Q35975553)

English

Low-molecular-weight heparin and cancer survival: review of the literature and pooled analysis of 1,726 patients treated for at least three months

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

0 references

Low-molecular-weight heparin and cancer survival: review of the literature and pooled analysis of 1,726 patients treated for at least three months (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

1 reference

based on heuristic

inferred from title

3

object named as

Alfonso Iorio

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

author name string

Serenella Conti

1

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Francesco Guercini

2

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 July 2003

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Pathophysiology of Haemostasis and Thrombosis: international journal on haemostasis and thrombosis research

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

197-201

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Effects of topical nasal anaesthesia on shift of breathing route in adults

1 reference

https://api.crossref.org/works/10.1159%2F000081508

21 January 2018

Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis

1 reference

https://api.crossref.org/works/10.1159%2F000081508

21 January 2018

Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials

1 reference

https://api.crossref.org/works/10.1159%2F000081508

21 January 2018

Low-molecular-weight heparin versus warfarin for prevention of recurrent venous thromboembolism: a randomized trial

1 reference

https://api.crossref.org/works/10.1159%2F000081508

21 January 2018

Low molecular weight heparin versus oral anticoagulants in the long-term treatment of deep venous thrombosis

1 reference

https://api.crossref.org/works/10.1159%2F000081508

21 January 2018

Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study

1 reference

https://api.crossref.org/works/10.1159%2F000081508

21 January 2018

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

1 reference

https://api.crossref.org/works/10.1159%2F000081508

21 January 2018

Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS).

1 reference

https://api.crossref.org/works/10.1159%2F000081508

21 January 2018

Identifiers

10.1159/000081508

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35975553&oldid=2010822703"